Bone marrow-derived mesenchymal stem cells prevent alopecia areata development through the inhibition of NKG2D expression: A pilot study 1 
| BACKGROUND
Hair follicle (HF) is an immune-privileged site. When the HF immune privilege is collapsed, CD4 and CD8 T cells, and some natural killer (NK) cells, accumulate around the autoantigens of the hair bulb and contribute to the development of alopecia areata (AA). [1] Th1 cytokines and chemokines, such as interferon (IFN)G, CXCL9 and CXCL10, are predominantly detected in AA lesions and might induce the collapse of the hair follicle immune privilege. [2, 3] Recent studies have shown that a NK cell receptor, NKG2D-mediated signalling, has been strongly associated with the pathogenesis of AA. [4] The antibody-mediated blockade of IFNG prevented AA development in grafted mice and blocked the accumulation of CD8+NKG2D+ T cells in the skin. [5] According to recent conceptions of pathology, the restoration or prevention of the collapse of HF immune privilege eventually leads to a more effective management of AA.
Mesenchymal stem cells (MSCs) show immunomodulatory and
anti-inflammatory effects on immune cells and are proposed as an approach to immunomodulation therapy, such as chronic inflammation or autoimmune disorders. [6] The effects of MSCs on AA have not yet been studied.
| QUESTIONS ADDRESSED
Alopecia areata is an inflammatory cytokine-mediated disease, in which IFNG is predominantly detected. Therefore, we examined whether
MSCs can be useful for the prevention of the AA development.
F I G U R E 1 Mesenchymal stem cells suppress the incidence of AA. Skin from AA-affected mice was grafted to 24 juvenile normal-haired mice. MSCs were intravenously injected into 13 skin-grafted mice. A, AA development was observed for 15 wks, and the incidence of AA was indicated as a percentage. B, At 3 and 15 wks after transplantation, the mice were photographed. Hair loss was indicated with white dotted lines. C-E, MSC treatment decreased IFNG, CXCL9 and CXCL10 levels in the sera of mice. The serum samples were obtained at weeks of 0, 3, 5, 6, 10 and 15, and the proteins were analysed using Luminex technology. The data represent the means ± SD of two independent experiments. † P < .05, *P < .01, **P < .001 compared with MSC-treated mice. PC, positive control AA group; MSC, MSC-injected AA group 
| RESULTS
Mice treated with MSCs showed decreased AA incidence compared with that of the control group ( Figure 1A , Table S1 ). After 3 weeks, hair loss was first observed in four mice among the 11 mice in the control group (36%), but not in the MSC-treated group. After 5 weeks, hair loss was observed in seven mice among the control group (64%). After 15 weeks, extensive hair loss was observed in 10 mice among the control group (91%), whereas only three of the 13 mice in the MSC-treated group (23%) showed AA incidence ( Figure 1B ). Because IFNG, CXCL9 and CXCL10 were increased during the development of AA, [2, 7] we examined whether MSCs inhibit AA-related factors. Serum samples were obtained at weeks 0, 3, 5,
6, 10 and 15 and analysed using Luminex technology. IFNG concentration was significantly increased during the AA development. The histological analysis revealed that inflammatory cells infiltrated in the dermis, subcutaneous fat and around dermal papilla after 9 weeks in the control group. There were dystrophic hairs with lymphocyte infiltrations. After 15 weeks, dense inflammatory cell infiltration around the dermal papilla was still observed in the control group.
However, mice treated with MSCs showed less cell infiltration in the dermis and the number of HF was not decreased in the MSC-treated group compared with the control group ( Figure 2A , Table S2a ). CD3 T cells were significantly increased in the epidermis and hair follicles in the control skin lesion (Fig. S1 , Table S3 ). NKG2D-expressing CD8 T cells infiltrate the surrounding HF in humans with AA. [3, 4] We investigated whether MSCs inhibit CD8+NKG2D+ T-cell infiltration in AA skin lesions. The CD8+NKG2D+ T cells were less observed in MSCtreated skin lesions than in control skin ( Figure 2B , Table S2a ). Next, we examined whether MSCs inhibit NKG2D expression. We isolated lymphocytes from the spleen and lymph nodes of AA-developed mice, and lymphocytes were stimulated using anti-CD3 and anti-CD28 antibodies in the presence or absence of MSCs. In consistent with the previous published results, T-cell proliferation and IFNG and IL17, which play a potential role in the pathogenesis of AA, productions were inhibited by MSCs (Fig. S2a-c) . In addition, we found that TCR signalling induced Nkg2d mRNA expression which was significantly decreased by MSC treatment (Fig. S2d) . Probably, MSCs inhibit Nkg2d mRNA F I G U R E 2 A, Mesenchymal stem cells prevent cell infiltration around hair follicles in the MSC-treated mice. Skin biopsies were taken 9 and 15 wks after transplantation and assessed for inflammatory cell infiltration. MSC-treated mice exhibited substantially reduced inflammation as assessed by haematoxylin and eosin. Cell infiltration around the dermal papilla is indicated with black arrows. Dystrophic hairs with lymphocyte infiltration are indicated with white arrows. At 15 wks, the skin obtained from the margin of AA patch showed decreased number of hair follicles.
(The areas indicated with yellow dotted lines) B, MSC treatment suppressed CD8+NKG2D+ T-cell infiltration in skin lesions. At 9 and 15 wks after transplantation, the skin specimens were stained with anti-CD8 and anti-NKG2D antibodies, and subsequently, CD8+ and NKG2D+ cells were identified using Alexa Fluor 488-and 647-conjugated antibodies, respectively. The nucleus was stained with DAPI. CD8+NKG2D+ T cells were indicated as white arrows expression. These preliminary results in an AA mice model suggest that
MSCs prevent the AA development through the suppression of CD3
and CD8+NKG2D+ T-cell infiltration in the AA skin lesions and the inhibition of the AA-related factors such as IFNG, CXCL9 and CXCL10.
| CONCLUSION
The 
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